Global Veterinary Anti-infectives Market
Veterinary Healthcare

Veterinary Anti-infectives Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the veterinary anti-infectives market?

In the past few years, the size of the veterinary anti-infectives market has seen a significant increase. It is projected to expand from $5.54 billion in 2024 to $6.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The growth experienced in the historical period can be linked to factors such as a rise in pet ownership, the prevalence of infectious diseases, advancements in veterinary medicine, heightened awareness, and government initiatives.

What will be the veterinary anti-infectives market size in the future?

In the coming years, the veterinary anti-infectives market is predicted to experience robust growth. The market size is anticipated to reach a value of $8.74 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this growth during the forecast period encompass the ongoing increase in pet population, the rise of zoonotic diseases, the globalization of pet trade, and greater spending on veterinary healthcare. The forecast period is expected to see several major trends including technological innovation, enhanced use of biologicals, the merging of telehealth into veterinary services, a shift towards natural and herbal alternatives, the growth of e-commerce in the veterinary pharmaceutical sector, and increased collaborations and partnerships.

Get your veterinary anti-infectives market report here!

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What main drivers are fueling expansion in the veterinary anti-infectives market?

The upward trend in the veterinary anti-infectives market is anticipated due to the expected rise in pet ownership. Owning a domestic pet such as a dog or cat at home constitutes pet ownership. More and more young individuals are opting to adopt pets considering them as family members, others choose to adopt out of a sense of compassion, loyalty, and a means to combat loneliness. For example, there was a significant growth in pet ownership in Australia in 2022, as reported by Animal Medicines Australia, a non-governmental organization based in Australia. The number of pet owners reached 28,730.8 in 2022, a 24% rise from 39% in 2021. This demonstrates a robust upward pattern in pet adoption along with an investment in pet care. The popularity of pets among Australian households, which is evidenced by the increase in pet ownership, is consequently fuelling the demand in the veterinary anti-infectives market.

What key areas define the segmentation of the global veterinary anti-infectives market?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Who are the dominant players expanding their reach in the veterinary anti-infectives market?

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

How are evolving market trends shaping veterinary anti-infectives Strategies?

Rapid advancements in technology are a significant trend on the rise in the field of veterinary anti-infectives. Major market players are employing state-of-the-art technologies to maintain their foothold in the industry. For example, in February 2022, US-based Elanco Animal Health Incorporated, known for its pharmaceutical products and vaccines for pets and livestock, unveiled its latest addition, Increxxa – an innovative solution against livestock respiratory disease. Delivered through direct injections, Increxxa, fortified by the key ingredient, tulathromycin, rapidly targets the infection site in the lungs. This allows for swift action and extended half-life, enabling the cattle to develop a robust defense mechanism. Specifically designed for veterinary usage, tulathromycin, which is the active component in Increxxa, effectively mitigates the adverse effects of bovine respiratory disease.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7802

Which regions are emerging as leaders in the veterinary anti-infectives market?

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Veterinary Antibiotics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Probiotics In Animal Feed Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/probiotics-in-animal-feed-global-market-report

Animal Antibiotics and Antimicrobials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *